At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 15, 2026 at 18:52 ET
Four Oruka Therapeutics insiders (CEO, COO, General Counsel, and a Director) sold a total of ~$2.67M in open-market transactions over a 5-day window. The sales represent only 0.06% of the company's $4.2B market cap, making them immaterial and likely routine portfolio diversification.
- CEO Lawrence Klein sold 1,729 shares for ~$120K on June 15.
- COO Laura Sandler sold 600 shares for ~$42K on June 15.
- General Counsel Paul Quinlan sold 733 shares for ~$51K on June 15.
- Director Carl Dambkowski sold 35,000 shares (two transactions) for ~$2.45M on June 11-12.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access